Cargando…

Antibody-Targeted Imaging of Gastric Cancer

The specificity of antibodies for antigens overexpressed or uniquely expressed in tumor cells makes them ideal candidates in the development of bioconjugates for tumor imaging. Molecular imaging can aid clinicians in the diagnosis of gastric tumors and in selecting patients for therapies targeting r...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mandleywala, Komal, Shmuel, Shayla, Pereira, Patricia M. R., Lewis, Jason S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7587187/ https://www.ncbi.nlm.nih.gov/pubmed/33050602 http://dx.doi.org/10.3390/molecules25204621

Ejemplares similares

PET and Optical Imaging of Caveolin-1 in Gastric Tumors
por: Surendra Panikar, Sandeep, et al.
Publicado: (2023)

Temporal Modulation of HER2 Membrane Availability Increases Pertuzumab Uptake and Pretargeted Molecular Imaging of Gastric Tumors
por: Pereira, Patrícia M.R., et al.
Publicado: (2019)

Caveolin-1 temporal modulation enhances antibody drug efficacy in heterogeneous gastric cancer
por: Pereira, Patrícia M. R., et al.
Publicado: (2022)

In Vivo Biorthogonal Antibody Click for Dual Targeting and Augmented Efficacy in Cancer Treatment
por: Panikar, Sandeep Surendra, et al.
Publicado: (2023)

(89)Zr-PET imaging of DNA double-strand breaks for the early monitoring of response following α- and β-particle radioimmunotherapy in a mouse model of pancreatic ductal adenocarcinoma
por: Poty, Sophie, et al.
Publicado: (2020)

Delivery of polymeric nanostars for molecular imaging and endoradiotherapy through the enhanced permeability and retention (EPR) effect
por: Goos, Jeroen A.C.M., et al.
Publicado: (2020)

Statins enhance the efficacy of HER2-targeting radioligand therapy in drug-resistant gastric cancers
por: Rao, Yi, et al.
Publicado: (2023)

Anti-claudin 18.2 antibody as new targeted therapy for advanced gastric cancer
por: Singh, Prabhsimranjot, et al.
Publicado: (2017)

HAI-178 antibody-conjugated fluorescent magnetic nanoparticles for targeted imaging and simultaneous therapy of gastric cancer
por: Wang, Can, et al.
Publicado: (2014)

State-of-the-Art of Monoclonal Antibodies for the Treatment of Gastric Cancer
por: Basile, Debora, et al.
Publicado: (2021)

BRCAA1 monoclonal antibody conjugated fluorescent magnetic nanoparticles for in vivo targeted magnetofluorescent imaging of gastric cancer
por: Wang, Kan, et al.
Publicado: (2011)

Therapeutic potential of lactoferrin-coated iron oxide nanospheres for targeted hyperthermia in gastric cancer
por: Attri, Komal, et al.
Publicado: (2023)

Radiolabeled Antibodies for Cancer Imaging and Therapy
por: Parakh, Sagun, et al.
Publicado: (2022)

Giant Dedifferentiated Gastric Liposarcoma: Largest to Date
por: Baker, William G, et al.
Publicado: (2023)

Cathepsin S as a target in gastric cancer
por: da Costa, Adriano Carneiro, et al.
Publicado: (2020)

Novel targeted agents for gastric cancer
por: Liu, Lian, et al.
Publicado: (2012)

Her-2 Targeted Therapy in Advanced Urothelial Cancer: From Monoclonal Antibodies to Antibody-Drug Conjugates
por: Albarrán, Víctor, et al.
Publicado: (2022)

Antibody Targeting of Eph Receptors in Cancer
por: Janes, Peter W., et al.
Publicado: (2020)

Helicobacter pylori Antibody Titer and Gastric Cancer Screening
por: Kishikawa, Hiroshi, et al.
Publicado: (2015)

Evaluation of (68)Ga-Labeled MG7 Antibody: A Targeted Probe for PET/CT Imaging of Gastric Cancer
por: Xu, Bing, et al.
Publicado: (2015)

BRCAA1 antibody- and Her2 antibody-conjugated amphiphilic polymer engineered CdSe/ZnS quantum dots for targeted imaging of gastric cancer
por: Li, Chao, et al.
Publicado: (2014)

Ion Channel Targeting with Antibodies and Antibody Fragments for Cancer Diagnosis
por: Duranti, Claudia, et al.
Publicado: (2019)

Targeting Wnt Signaling for the Treatment of Gastric Cancer
por: Koushyar, Sarah, et al.
Publicado: (2020)

Molecular target: pan-AKT in gastric cancer
por: Kang, Byung Woog, et al.
Publicado: (2020)

Metastatic gastric cancer – focus on targeted therapies
por: Meza-Junco, Judith, et al.
Publicado: (2012)

Molecular targeted therapy for advanced gastric cancer
por: Kim, Jong Gwang
Publicado: (2013)

The progress of targeted therapy in advanced gastric cancer
por: Qiu, Miao-zhen, et al.
Publicado: (2013)

Molecular targeted therapy for the treatment of gastric cancer
por: Xu, Wenting, et al.
Publicado: (2016)

Targeted and novel therapy in advanced gastric cancer
por: Selim, Julie H., et al.
Publicado: (2019)

HIF in Gastric Cancer: Regulation and Therapeutic Target
por: Li, Mengqing, et al.
Publicado: (2022)

Research Progress for Targeting Deubiquitinases in Gastric Cancers
por: An, Tao, et al.
Publicado: (2022)

The Extracellular Matrix: An Accomplice in Gastric Cancer Development and Progression
por: Moreira, Ana Margarida, et al.
Publicado: (2020)

Current Status of Radiolabeled Monoclonal Antibodies Targeting PSMA for Imaging and Therapy
por: Abusalem, Mohammed, et al.
Publicado: (2023)

Molecular classification of gastric cancer: Towards a pathway-driven targeted therapy
por: Riquelme, Ismael, et al.
Publicado: (2015)

Gastric Cancer Staging: Is It Time for Magnetic Resonance Imaging?
por: Renzulli, Matteo, et al.
Publicado: (2020)

Application of Multiphoton Microscopic Imaging in Study of Gastric Cancer
por: Wang, Xiaoying, et al.
Publicado: (2022)

Imaging in Gastric Cancer: Current Practice and Future Perspectives
por: Giandola, Teresa, et al.
Publicado: (2023)

New Intraoperative Imaging Tools and Image-Guided Surgery in Gastric Cancer Surgery
por: Knospe, Luise, et al.
Publicado: (2022)

Antibody targeting of phosphatidylserine for the detection and immunotherapy of cancer
por: Belzile, Olivier, et al.
Publicado: (2018)

CAR-T Cell Therapy—An Overview of Targets in Gastric Cancer
por: Bębnowska, Dominika, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_8h8risun1mll8ubn4eln5t2hpm